The ectoenzyme γ-glutamyl transpeptidase regulates antiproliferative effects of S-nitrosoglutathione on human T and B lymphocytes

Journal of Immunology

Volumn 163, Issue 4, 1999, Pages 1845-1852

  Henson, Sarah E ^a   Nichols, Timothy C ^b   Holers, V Michael ^b   Karp, David R ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Simmons Arthritis Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; S NITROSOGLUTATHIONE;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; LYMPHOMA CELL LINE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; COPPER; DEOXYRIBONUCLEOTIDES; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; INTRACELLULAR FLUID; LYMPHOCYTE ACTIVATION; NITRITES; NITROSO COMPOUNDS; S-NITROSOGLUTATHIONE; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0033566676     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Meister, A., S. S. Tate, and O. W. Griffith. 1981. γ-glutamyl transpeptidase. Methods Enzymol. 77:237.
2. Lieberman, M. W., R. Barrios, B. Z. Carter, H. G. M., R. M. Lebovitz, S. Rajagopalan, A. R. Sepulveda, Z.-Z. Shi, and D.-F. Wan. 1995. γ-Glutamyl transpeptidase. Am. J. Pathol. 147:1175.
3. Lieberman, M. W., A. L. Wiseman, Z. Z. Shi, B. Z. Carter, R. Barrios, C. N. Ou, P. Chevez-Barrios, Y. Wang, G. M. Habib, J. C. Goodman, S. L. Huang, R. M. Lebovitz, and M. M. Matzuk. 1996. Growth retardation and cysteine deficiency in γ-glutamyl transpeptidase-deficient mice. Proc. Natl. Acad. Sci. USA 91:7923.
4. Novogrodsky, A., S. S. Tate, and A. Meister. 1976. γ-Glutamyl transpeptidase, a lymphoid cell-surface marker: relationship to blastogenesis, differentiation, and neoplasia. Proc. Natl. Acad. Sci. USA 73:2414.
5. Grisk, O., U. Küster, and S. Ansorge. 1993. The activity of γ-glutamyl transpeptidase (γ-GT) in populations of mononuclear cells from human peripheral blood. Biol. Chem. Hoppe Seyler 374:287.
6. Marathe, G. V., N. S. Damle, R. H. Haschemeyer, and S. S. Tate. 1980. Localization of γ-glutamyl transpeptidase in lymphoid cells. FEBS Lett. 115:273.
7. Tager, M., A. Ittenson, A. Franke, A. Frey, H. G. Gassen, and S. Ansorge. 1995. γ-Glutamyl transpeptidase: cellular expression in populations of normal human mononuclear cells and patients suffering from leukemias. Ann. Hematol 70:237.
8. Nichols, T. C., J. M. Guthridge, D. R. Karp, H. Molina, D. R. Fletcher, and V. M. Holers. 1998. γ-Glutamyl transpeptidase, an ectoenzyme regulator of intracelluar redox potential, is a component of TM4 signal transduction complexes. Eur. J. Immunol. 28:4123.
9. Hogg, N., R. J. Singh, E. Konorev, J. Joseph, and B. Kalyanaraman. 1997. S-Nitrosoglutathione as a substrate for γ-glutamyl transpeptidase. Biochem. J. 323: 477.
10. Askew, S. C., A. R. Butler, F. W. Flitney, G. D. Kemp, and I. L. Megson. 1995. Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-DL-penicillamine and S-nitrosoglutathione. Bioorg. Med. Chem. 3:1.
11. Mathews, W. R., and S. W. Kerr. 1993. Biological activity of S-nitrosothiols: the role of nitric oxide. J. Pharmacol. Exp. Ther. 267:1529.
12. Gibson, A., R. Babbedge, S. R. Brave, S. L. Hart, A. J. Hobbs, J. F. Tucker, P. Wallace, and P. K. Moore. 1992. An investigation of some S-nitrosothiols, and of hydroxy-arginine, on the mouse anococcygeus. Br. J. Pharmacol. 107:715.
13. Radomski, M. W., D. D. Rees, A. Dutra, and S. Moncada. 1992. 5-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br. J. Pharmacol. 107: 745.
14. Stamler, J. S. 1995. S-Nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups. Curr. Top. Microbiol. Immunol. 196:19.
15. Stamler, J. S., L. Jia, J. P. Eu, T. J. McMahon, I. T. Demchenko, J. Bonaventura, K. Gernert, and C. A. Piantadsosi. 1997. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 276:2034.
16. Merryman, P. F., R. M. Clancy, X. Y. He, and S. B. Abramson. 1993. Modulation of human T cell responses by nitric oxide and its derivative, S-nitrosoglutathione. Arthritis Rheum. 36:1414.
17. Akaike, T., K. Inoue, T. Okamoto, H. Nishino, M. Otagiri, S. Fujii, and H. Maeda. 1997. Nanomolar quantification and identification of various nitrosothiols by high performance liquid chromatography coupled with flow reactors of metals and Griess reagent. J. Biochem. 122:459.
18. Karp, D. R., R. N. Jenkins, and E. O. Long. 1992. Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins. Proc. Natl. Acad. Sci USA 89:9657.
19. Goodspeed, D. C., T. J. Dunn, C. D. Miller, and H. C. Pitot. 1989. Human γ-glutamyl transpeptidase cDNA: comparison of hepatoma and kidney mRNA in the human and rat. Gene 76:1.
20. Stole, E., T. K. Smith, J. M. Manning, and A. Meister. 1994. Interaction of γ-glutamyl transpeptidase with acivicin. J. Biol. Chem. 269:21435.
21. Sherman, P. A., and J. A. Fyfe. 1989. Enzymatic assay of deoxyribonucleotide triphosphates using synthetic oligonucleotides as template primers. Anal. Biochem. 180:222.
22. Singh, R. J., N. Hogg, J. Joseph, and B. Kalyanaraman. 1996. Mechanism of nitric oxide release from S-nitrosothiols. J. Biol. Chem. 271:18596.
23. Lepoivre, M., B. Chenais, A. Yapo, G. Lemaire, L. Thelander, and J. P. Tenu. 1990. Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J. Biol. Chem. 265:14143.
24. Kwon, N. S., D. J. Stuehr, and C. F. Nathan. 1991. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med. 174: 761.
25. Lepoivre, M., F. Fieschi, J. Coves, L. Thelander, and M. Fontecave. 1991. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun. 179:442.
26. Lepoivre, M., J. M. Flaman, and Y. Henry. 1992. Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide. J. Biol. Chem. 267:22994.
27. Roy, B., M. Lepoivre, Y. Henry, and M. Fontecave. 1995. Inhibition of ribonucleotide reductase by nitric oxide derived from thionitrites: reversible modifications of both subunits. Biochemistry 34:5411.
28. Novogrodsky, A., S. S. Tate, and A. Meister. 1976. γ-glutamyl transpeptidase, a lymphoid cell-surface marker: relationship to blastogenesis, differentiation, and neoplasia. Proc. Natl. Acad. Sci. USA 73:2414.
29. + T cells that exhibit a transendothelial migratory capacity. J. Immunol. 154:3062.
30. Pietschmann, P., J. J. Cush, P. E. Lipsky, and N. Oppenheimer-Marks. 1992. Identification of subsets of human T cells capable of enhanced transendothelial migration. J. Immunol. 149:1170.
31. - memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 39:344.
32. MacMicking, J. D., R. J. North, R. LaCourse, J. S. Mudgett, S. K. Shah, and C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243.
33. Butler, A. R., and P. Rhodes. 1997. Chemistry, analysis and biological roles of S-nitrosothiols. Anal. Biochem. 249:1.
34. Ohta, H., J. N. Bates, S. J. Lewis, and W. T. Talman. 1997. Actions of S-nitrosocysteine in the nucleus tractus solitarii are unrelated to release of nitric oxide. Brain Res. 746:98.
35. Mannick, J. B., K. Asano, K. Izumi, E. Kieff, and J. S. Stamler. 1994. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137.
36. Mannick, J. B., X. Q. Miao, and J. S. Stamler. 1997. Nitric oxide inhibits Fas-induced apoptosis. J. Biol. Chem. 272:24125.
37. Kim, Y.-M., R. V. Talanian, and T. R. Billiar. 1997. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J. Biol. Chem. 272:31138.
38. Messmer, U. K., and B. Brune. 1996. Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. Biochem. J. 319:299.
39. Messmer, U. K., J. C. Reed, and B. Brilne. 1996. Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J. Biol. Chem. 271:20192.
40. Xie, K. C., and W. Plunkett. 1996. Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-ß-D-arabinofuranosyl)adenine. Cancer Res. 56:3030.
41. Lander, H. M., D. P. Hajjar, B. L. Hempstead, U. A. Mirza, B. T. Chait, S. Campbell, and L. A. Quilliam. 1997. A molecular redox switch on p21(ras): structural basis for the nitric oxide-p21(ras) interaction. J. Biol. Chem. 272:4323.
42. Lander, H. M., A. T. Jacovina, R. J. Davis, and J. M. Tauras. 1996. Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J. Biol. Chem. 271:19705.